BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8960109)

  • 1. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
    Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
    Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
    Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
    J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
    van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
    Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
    Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
    De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
    Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
    Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
    Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
    Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
    Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 variant exons in leukemia and lymphoma.
    Akisik E; Bavbek S; Dalay N
    Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
    Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K
    J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
    Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
    Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.